A routine urine ACR ordered for diabetes follow-up often reveals mildly elevated albumin levels—and it’s increasingly becoming one of the most searched OPD topics among clinicians. Microalbuminuria is no longer just a renal parameter; it is an early marker of endothelial dysfunction and heightened cardiovascular risk, even before eGFR declines. In patients with diabetes, hypertension, obesity, or metabolic syndrome, a raised urine albumin–creatinine ratio (30–300 mg/g) may signal early target organ damage.
Importantly, values should be confirmed on repeat testing (preferably first morning samples) before labelling. Beyond Glycemic control, blood pressure optimization, especially with ACE inhibitors or ARBs, remains central to management. Emerging data also highlight the renoprotective benefits of SGLT2 inhibitors across diabetic and non-diabetic CKD populations, shifting how we approach…
